Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20051742HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS20022496HPVENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44015404HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44023634HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44012773HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44041591HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44041670HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44051073HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44047171HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TVIS44047121HTLV-1ENSG00000140009.19protein_codingESR2NoNo2100Q92731
TCGA Plot Options
Drug Information
GeneESR2
DrugBank IDDB13955
Drug NameEstradiol dienanthate
Target IDBE0000792
UniProt IDQ92731
Regulation Typeagonist
PubMed IDs17464340; 2011412
CitationsVijayanathan V, Greenfield NJ, Thomas TJ, Ivanova MM, Tyulmenkov VV, Klinge CM, Gallo MA, Thomas T: Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta. Biochem Cell Biol. 2007 Feb;85(1):1-10.@@Sasson S: Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor. Pathol Biol (Paris). 1991 Jan;39(1):59-69.
GroupsApproved; Investigational; Vet_approved
Direct ClassificationSteroid esters
SMILESCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(OC(=O)CCCCCC)=CC=C4[C@H]3CC[C@]12C
Pathways
PharmGKB
ChEMBL